SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Chemours Co – ‘10-Q’ for 3/31/18 – ‘EX-10.3’

On:  Friday, 5/4/18, at 4:10pm ET   ·   For:  3/31/18   ·   Accession #:  1564590-18-10990   ·   File #:  1-36794

Previous ‘10-Q’:  ‘10-Q’ on 11/3/17 for 9/30/17   ·   Next:  ‘10-Q’ on 8/3/18 for 6/30/18   ·   Latest:  ‘10-Q’ on 10/27/23 for 9/30/23   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/04/18  Chemours Co                       10-Q        3/31/18  116:18M                                    ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report -- cc-10q_20180331                 HTML   1.02M 
 2: EX-10.2     Material Contract                                   HTML     55K 
 3: EX-10.3     Material Contract                                   HTML     62K 
 8: EX-95       Mine-Safety Disclosure                              HTML     40K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     40K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     40K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     34K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     34K 
15: R1          Document and Entity Information                     HTML     52K 
16: R2          Interim Consolidated Statements of Operations       HTML     84K 
                (Unaudited)                                                      
17: R3          Interim Consolidated Statements of Comprehensive    HTML    118K 
                Income (Loss) (Unaudited)                                        
18: R4          Interim Consolidated Balance Sheets                 HTML    120K 
19: R5          Interim Consolidated Balance Sheets                 HTML     43K 
                (Parenthetical)                                                  
20: R6          Interim Consolidated Statements of Stockholders'    HTML     75K 
                Equity (Unaudited)                                               
21: R7          Interim Consolidated Statements of Cash Flows       HTML    109K 
                (Unaudited)                                                      
22: R8          Background, Description of the Business and Basis   HTML     39K 
                of Presentation                                                  
23: R9          Recent Accounting Pronouncements                    HTML    222K 
24: R10         Significant Transactions and Events                 HTML     35K 
25: R11         Net Sales                                           HTML    170K 
26: R12         Restructuring, Asset-Related, and Other Charges,    HTML    138K 
                Net                                                              
27: R13         Other Income, Net                                   HTML     63K 
28: R14         Income Taxes                                        HTML     39K 
29: R15         Earnings Per Share of Common Stock                  HTML     78K 
30: R16         Accounts and Notes Receivable, Net                  HTML     57K 
31: R17         Inventories                                         HTML     59K 
32: R18         Property, Plant, and Equipment, Net                 HTML     66K 
33: R19         Other Assets                                        HTML     56K 
34: R20         Accounts Payable                                    HTML     53K 
35: R21         Other Accrued Liabilities                           HTML     73K 
36: R22         Debt                                                HTML     94K 
37: R23         Other Liabilities                                   HTML     64K 
38: R24         Commitments and Contingent Liabilities              HTML     71K 
39: R25         Equity                                              HTML     37K 
40: R26         Financial Instruments                               HTML     78K 
41: R27         Long-term Employee Benefits                         HTML     75K 
42: R28         Stock-based Compensation                            HTML     56K 
43: R29         Segment Information                                 HTML    162K 
44: R30         Subsequent Events                                   HTML     48K 
45: R31         Guarantor Condensed Consolidating Financial         HTML   1.17M 
                Information                                                      
46: R32         Recent Accounting Pronouncements (Policies)         HTML    222K 
47: R33         Recent Accounting Pronouncements (Tables)           HTML    206K 
48: R34         Net Sales (Tables)                                  HTML    150K 
49: R35         Restructuring, Asset-Related, and Other Charges,    HTML    131K 
                Net (Tables)                                                     
50: R36         Other Income, Net (Tables)                          HTML     62K 
51: R37         Earnings Per Share of Common Stock (Tables)         HTML     81K 
52: R38         Accounts and Notes Receivable, Net (Tables)         HTML     53K 
53: R39         Inventories (Tables)                                HTML     59K 
54: R40         Property, Plant, and Equipment, Net (Tables)        HTML     65K 
55: R41         Other Assets (Tables)                               HTML     56K 
56: R42         Accounts Payable (Tables)                           HTML     52K 
57: R43         Other Accrued Liabilities (Tables)                  HTML     73K 
58: R44         Debt (Tables)                                       HTML     92K 
59: R45         Other Liabilities (Tables)                          HTML     63K 
60: R46         Financial Instruments (Tables)                      HTML    108K 
61: R47         Long-term Employee Benefits (Tables)                HTML     74K 
62: R48         Stock-based Compensation (Tables)                   HTML     46K 
63: R49         Segment Information (Tables)                        HTML    158K 
64: R50         Guarantor Condensed Consolidating Financial         HTML   1.16M 
                Information (Tables)                                             
65: R51         Background, Description of the Business and Basis   HTML     33K 
                of Presentation (Narrative) (Details)                            
66: R52         Recent Accounting Pronouncements (Narrative)        HTML     39K 
                (Details)                                                        
67: R53         Recent Accounting Pronouncements (Impacts of        HTML     85K 
                Adoption of Topic 606 on Consolidated Statements                 
                of Operations) (Details)                                         
68: R54         Recent Accounting Pronouncements (Reclassification  HTML     85K 
                of Non-operating Pension and Other Post-retirement               
                Employee Benefit Income) (Details)                               
69: R55         Significant Transactions and Events (Narrative)     HTML     43K 
                (Details)                                                        
70: R56         Net Sales (Narrative) (Details)                     HTML     52K 
71: R57         Net Sales - Summary of Disaggregation of Net Sales  HTML     80K 
                by Geographical Region, Product Group, and Segment               
                (Details)                                                        
72: R58         Net Sales - Summary of Contract Balances from       HTML     39K 
                Contracts with Customers (Details)                               
73: R59         Net Sales - Summary of Contract Balances from       HTML     41K 
                Contracts with Customers (Parenthetical) (Details)               
74: R60         Restructuring, Asset-Related, and Other Charges,    HTML     39K 
                Net (Charges) (Details)                                          
75: R61         Restructuring, Asset-Related, and Other Charges,    HTML     47K 
                Net (Segment Earnings) (Details)                                 
76: R62         Restructuring, Asset-Related, and Other Charges,    HTML     89K 
                Net (Narrative) (Details)                                        
77: R63         Restructuring, Asset-Related, and Other Charges,    HTML     55K 
                Net (Restructuring Program Schedule) (Details)                   
78: R64         Other Income,Net (Components of Other Income)       HTML     43K 
                (Details)                                                        
79: R65         Other Income,Net (Components of Other Income)       HTML     41K 
                (Parenthetical) (Details)                                        
80: R66         Income Taxes (Narrative) (Details)                  HTML     47K 
81: R67         Earnings Per Share of Common Stock (Earnings per    HTML     52K 
                Share Calculation) (Details)                                     
82: R68         Earnings Per Share of Common Stock (Anti-dilutive   HTML     34K 
                Shares Excluded from Computation of Earnings per                 
                Share) (Details)                                                 
83: R69         Accounts and Notes Receivable, Net (Schedule of     HTML     43K 
                Accounts and Notes Receivable) (Details)                         
84: R70         Accounts and Notes Receivable, Net (Schedule of     HTML     40K 
                Accounts and Notes Receivable) (Parenthetical)                   
                (Details)                                                        
85: R71         Accounts and Notes Receivable, Net (Narrative)      HTML     35K 
                (Details)                                                        
86: R72         Inventories (Details)                               HTML     49K 
87: R73         Property, Plant, and Equipment, Net (Details)       HTML     52K 
88: R74         Property, Plant, and Equipment, Net (Narrative)     HTML     38K 
                (Details)                                                        
89: R75         Other Assets (Details)                              HTML     53K 
90: R76         Accounts Payable (Details)                          HTML     41K 
91: R77         Accounts Payable (Parenthetical) (Details)          HTML     40K 
92: R78         Other Accrued Liabilities (Details)                 HTML     64K 
93: R79         Debt (Components of Debt) (Details)                 HTML     74K 
94: R80         Debt (Senior Secured Credit Facilities) (Details)   HTML     53K 
95: R81         Debt (Build-to-suit Lease Obligation) (Details)     HTML     36K 
96: R82         Debt (Maturities and Fair Value) (Details)          HTML     60K 
97: R83         Other Liabilities (Details)                         HTML     52K 
98: R84         Other Liabilities (Parenthetical) (Details)         HTML     33K 
99: R85         Commitments and Contingent Liabilities              HTML    124K 
                (Litigation) (Narrative) (Details)                               
100: R86         Commitments and Contingent Liabilities              HTML     47K  
                (Environmental) (Narrative) (Details)                            
101: R87         Equity (Narrative) (Details)                        HTML     63K  
102: R88         Financial Instruments (Narrative) (Details)         HTML     48K  
103: R89         Financial Instruments (Schedule of the Fair Value   HTML     48K  
                of Derivative Instruments) (Details)                             
104: R90         Long-term Employee Benefits (Schedule of Net        HTML     58K  
                Periodic Pension Income and Amounts Recognized in                
                Other Comprehensive Income (Loss) (Details)                      
105: R91         Long-term Employee Benefits (Narrative) (Details)   HTML     38K  
106: R92         Stock-based Compensation (Narrative) (Details)      HTML     89K  
107: R93         Stock-based Compensation (Stock Option Weighted     HTML     45K  
                Average Assumptions) (Details)                                   
108: R94         Segment Information (Schedule of Segment            HTML     51K  
                Information) (Details)                                           
109: R95         Segment Information - (Reconciliation of EBITDA     HTML     63K  
                from Segments to Consolidated Net Income Before                  
                Income Taxes) (Details)                                          
110: R96         Subsequent Events (Details)                         HTML    154K  
111: R97         Guarantor Condensed Consolidating Financial         HTML    112K  
                Information (Condensed Consolidating Statements of               
                Comprehensive Income) (Details)                                  
112: R98         Guarantor Condensed Consolidating Financial         HTML    176K  
                Information (Condensed Consolidating Balance                     
                Sheets) (Details)                                                
113: R99         Guarantor Condensed Consolidating Financial         HTML    114K  
                Information (Condensed Consolidating Statements of               
                Cash Flows) (Details)                                            
115: XML         IDEA XML File -- Filing Summary                      XML    224K  
114: EXCEL       IDEA Workbook of Financial Reports                  XLSX    122K  
 9: EX-101.INS  XBRL Instance -- cc-20180331                         XML   6.07M 
11: EX-101.CAL  XBRL Calculations -- cc-20180331_cal                 XML    249K 
12: EX-101.DEF  XBRL Definitions -- cc-20180331_def                  XML    877K 
13: EX-101.LAB  XBRL Labels -- cc-20180331_lab                       XML   1.47M 
14: EX-101.PRE  XBRL Presentations -- cc-20180331_pre                XML   1.34M 
10: EX-101.SCH  XBRL Schema -- cc-20180331                           XSD    254K 
116: ZIP         XBRL Zipped Folder -- 0001564590-18-010990-xbrl      Zip    265K  


‘EX-10.3’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C: 

 

 

Exhibit 10.3

AWARD TERMS OF DEFERRED STOCK UNITS

GRANTED TO A NONEMPLOYEE DIRECTOR

UNDER THE CHEMOURS COMPANY EQUITY AND INCENTIVE PLAN

 

 

Introduction

You have been granted vested Deferred Stock Units (the “Award”) under The Chemours Company Equity and Incentive Plan (the “Equity and Incentive Plan”) in accordance with your Annual Deferral Election Form (the “Deferral Election Form”) under The Chemours Company Stock Accumulation and Deferred Compensation Plan for Directors (the “Deferred Compensation Plan” and, together with the Equity and Incentive Plan, the “Plans”).  The Award is subject to these Award Terms and the terms of the Plans and your Deferral Election Form, which are hereby incorporated by reference.  For purposes of the Equity and Incentive Plan, the Award shall be considered an “Other Stock-Based Award.”  To the extent that an Award Term conflicts with the Plans, the Plans shall govern.  Unless otherwise defined herein, the terms defined in the Equity and Incentive Plan shall have the same defined meanings in these Award Terms, including any appendices to these Award Terms (hereinafter, collectively referred to as the “Agreement”).  A copy of the Deferred Compensation Plan and your Deferral Election Form are available upon request.  A copy of the Equity and Incentive Plan, and related materials, such as the Equity and Incentive Plan prospectus, are available upon request or on the Merrill Lynch website at:

 

www.benefits.ml.com

 

Date of Grant[        ] (“Date of Grant”)

 

Type of AwardDeferred Stock Units

 

Number of Deferred
Stock Units Awarded[        ]

 

Dividend Equivalents

Dividends payable on the shares of Stock represented by your Deferred Stock Units (including whole and fractional Deferred Stock Units) will be allocated to your account in the form of additional Deferred Stock Units (whole and fractional) based upon the closing Stock price on the date of the dividend payment.  Any such additional Deferred Stock Units will be subject to the same terms and conditions as the Deferred Stock Units to which they relate.

 

Vesting

The Award is 100% vested.

 

Shareholder Rights

Deferred Stock Units are not shares of Stock.  They represent an unfunded and unsecured right to receive shares of Stock upon settlement.  Until the Deferred Stock Units are settled, you will not have any voting rights, the right to receive dividends (but you will have the right to receive additional Deferred Stock Units to the extent dividends are paid, as described above) or other rights of a shareholder.

 

Settlement

The Deferred Stock Units will be settled (meaning one share of Stock will be issued to you or your beneficiary (or estate, if there is no beneficiary), as applicable, for each Deferred Stock Unit, with any fractional Deferred Stock Unit

 


 

paid in cash) on the distribution date or event you elected in your Deferral Election Form, or if earlier, as soon as practicable after your death.  The value of any fractional Deferred Stock Unit will be based on the closing price of a share of Stock on the Deferred Stock Unit settlement date.

 

Taxes

The Deferred Stock Units are subject to various taxes upon settlement.  For U.S. residents, the Company is not required nor does it withhold taxes relating to the Deferred Stock Units; however, the Company will report proceeds on a Form 1099-MISC.  You are encouraged to consult a tax professional on more specifics.

  

Severability

The provisions of this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

 

Waiver

You acknowledge that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach of this Agreement.

 

Appendix

Notwithstanding any provisions in these Award Terms, the Deferred Stock Units shall be subject to the additional terms and conditions set forth in Appendix A to this Agreement and to any special terms and provisions as set forth in Appendix B for your country, if any.  Moreover, if you relocate to one of the countries included in Appendix B, the special terms and conditions for such country will apply to you, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons.  Appendix A and B constitute part of these Award Terms.

 

Imposition of Other

Requirements

The Company reserves the right to impose other requirements on your participation in Plans, on the Deferred Stock Units and on any shares of Stock issued under the Equity and Incentive Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

 


 


 

APPENDIX A

ADDITIONAL TERMS AND CONDITIONS

This Appendix includes additional terms and conditions that govern the Deferred Stock Units. These terms and conditions are in addition to, or, if so indicated, in place of, the terms and conditions set forth in the Award Terms. Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to them in the Award Terms or the Equity and Incentive Plan.

Data Privacy

You hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this Agreement and any other Deferred Stock Unit grant materials by and among the Company and its Subsidiaries or Affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plans.

 

You understand that the Company may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number (e.g., resident registration number), salary, nationality, job title, any stock or directorships held in the Company, details of all Deferred Stock Units or any other entitlement to stock awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the exclusive purpose of implementing, administering and managing the Plans (“Data”).

 


 

 

You understand that Data will be transferred to any third parties assisting the Company with the implementation, administration and management of the Plans. You understand that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than your country. You understand that you may request a list with the names and addresses of any potential recipients of the Data by contacting the Company’s Corporate Secretary. You authorize the Company, its Subsidiaries and Affiliates, and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plans to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing your participation in the Plans. You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plans. You understand that you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consent herein, in any case without cost, by contacting in writing the Company’s Corporate Secretary. Further, you understand that you are providing the consent herein on a purely voluntary basis.  If you do not consent, or if you later seek to revoke your consent, your status or service and career with the Company will not be affected; the only consequence of refusing or withdrawing your consent is that the Company would not be able to grant you Deferred Stock Units or other awards or administer or maintain such awards (i.e., the award would be null and void). Therefore, you understand that refusing or withdrawing

your consent may affect your ability to participate in the Plans.  For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact the Company’s Corporate Secretary.

Nature of Grant

By participating in the Plans, you acknowledge, understand and agree that:

 

(a)the Plans are established voluntarily by the Company, they are discretionary in nature and may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plans; (b) the grant of the Deferred Stock Units is voluntary and occasional and does not create any contractual or other right to receive future grants, or benefits in lieu of Deferred Stock Units, even if Deferred Stock Units have been granted in the past; (c) all decisions with respect to future grants of Deferred Stock Units, if any, will be at the sole discretion of the Company; (d) you are voluntarily participating in the Plans; (e) the Deferred Stock Units are not intended to replace any pension rights or compensation; (f) unless otherwise agreed with the Company, the Deferred Stock Units and the shares of Stock subject to the Deferred Stock Units, and the income and value of same, are not granted as consideration for, or in connection with, any service you may provide as a director of a Subsidiary or Affiliate; (g) the Deferred Stock Units and the income and value of same are not part of normal or expected compensation for any purpose including, without limitation, calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments; (h) the future value of the underlying shares of Stock is unknown, indeterminable and cannot be predicted with certainty; (i) for purposes of the Deferred Stock Units, your service relationship will be considered terminated as of the date you are no longer actively providing services to the Company or one of its Subsidiaries or Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of laws in the jurisdiction where you reside or provide services, and the Committee shall have the exclusive discretion to determine when you are no longer actively providing services for purposes of the Deferred Stock Units (including whether you may still be considered to be providing services while on an approved leave of absence); (j) unless otherwise provided in the Plans or by the Company in its discretion, the Deferred Stock Units and the benefits evidenced by this Agreement do not create any entitlement to have the Deferred Stock Units or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the shares of the Company; and (k) neither the Company, nor any Subsidiary or Affiliate shall be liable for any foreign exchange rate fluctuation between your local currency and the U.S. dollar that may affect the value of the Deferred Stock Units or of any amount due to you pursuant to the settlement of the Deferred Stock Units or the subsequent sale of any shares of Stock acquired upon settlement.

 


 

No Advice Regarding Grant

The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding your participation in the Plan, or your acquisition or sale of the underlying shares of Stock. You are hereby advised to consult with your own personal tax, legal and financial

advisors regarding your participation in the Plans before taking any action related to the Plans.

Venue

Any and all disputes relating to, concerning or arising from this Agreement, or relating to, concerning or arising from the relationship between the parties evidenced by the Deferred Stock Units or this Agreement, shall be brought and heard exclusively in the United States District Court for the District of Delaware or the Delaware Superior Court, New Castle County. Each of the parties hereby represents and agrees that such party is subject to the personal jurisdiction of said courts; hereby irrevocably consents to the jurisdiction of such courts in any legal or equitable proceedings related to, concerning or arising from such dispute, and waives, to the fullest extent permitted by law, any objection which such party may now or hereafter have that the laying of the venue of any legal or equitable proceedings related to, concerning or arising from such dispute which is brought in such courts is improper or that such proceedings have been brought in an inconvenient forum.

Language

If you have received this Agreement or any other document related to this Agreement translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

Electronic Delivery and Acceptance

The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plans by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the Plans through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

Insider Trading/Market Abuse Laws

You acknowledge that, depending on your country of residence, you may be subject to insider trading restrictions and/or market abuse laws, which may affect your ability to acquire or sell shares of Stock or rights to shares of Stock (e.g., Deferred Stock Units) under the Plans during such times as you are considered to have “inside information” regarding the Company (as defined by the laws in your country). Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under the Company’s insider trading policy.  You acknowledge that it is your responsibility to comply with any applicable restrictions, and you are advised to speak to your personal advisor on this matter.

Foreign Asset/ Account Reporting Requirements

Your country may have certain foreign asset and/or account reporting requirements which may affect your ability to acquire or hold shares of Stock under the Plans or cash received from participating in the Plans (including from any sale proceeds arising from the sale of shares of Stock) in a brokerage or bank account outside your country.  You may be required to report such accounts, assets or transactions to the tax or other authorities in your country.  You also may be required to repatriate sale proceeds or other funds received as a result of your participation in the Plans to your country through a designated bank or broker and/or within a certain time after receipt. You acknowledge that it is your responsibility to comply with such regulations, and you should consult your personal legal advisor for any details.

 

 


 

APPENDIX B

COUNTRY-SPECIFIC TERMS AND CONDITIONS

This Appendix includes additional terms and conditions that govern the Deferred Stock Units granted to you under the Plans if you reside in one of the countries listed herein. These terms and conditions are in addition to, or if so indicated, in place of the terms and conditions set forth in the Award Terms or Appendix A.

You should be aware that local exchange control laws may apply to you as a result of your participation in the Plans. By accepting the Deferred Stock Units, you agree to comply with applicable exchange control laws associated with your participation in the Plans.  If you have any questions regarding your responsibilities in this regard, you agree to seek advice from your personal legal advisor, at your own cost, and further agree that neither the Company nor any Subsidiary or Affiliate will be liable for any fines or penalties resulting from your failure to comply with applicable laws.

If you are a citizen or resident of a country other than the one in which you are currently working or are considered a resident of another country for local law purposes, the terms and conditions contained herein may not be applicable to you, and the Company shall, in its discretion, determine to what extent the terms and conditions contained herein shall apply to you.

CANADA

Deferred Stock Units Settled in Shares Only.  Notwithstanding any discretion contained in Section 6(b)(iii) of the Equity and Incentive Plan, or any provision in this Agreement to the contrary, Deferred Stock Units granted to you in Canada will be settled in shares of Stock only.

Securities Law Information.  You are permitted to sell shares of Stock acquired under the Award through a broker acceptable to the Company, provided the resale of shares of Stock acquired under the Award takes place outside of Canada through the facilities of a stock exchange on which the shares of Stock are listed.  The shares of Stock are currently listed on the New York Stock Exchange.

 

 

 

6


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:5/4/183,  4,  8-K
For Period end:3/31/18
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/27/24  Chemours Co.                      10-K       12/31/23  200:50M                                    Donnelley … Solutions/FA
 2/10/23  Chemours Co.                      10-K       12/31/22  185:39M                                    Donnelley … Solutions/FA
 2/11/22  Chemours Co.                      10-K       12/31/21  185:36M                                    ActiveDisclosure/FA
 2/12/21  Chemours Co.                      10-K       12/31/20  182:38M                                    ActiveDisclosure/FA
Top
Filing Submission 0001564590-18-010990   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 3:13:14.1pm ET